A pioneer in community-based cancer care, Texas Oncology provides highquality cancer care and leading-edge technology and therapy options to patients where they live.
Our evidence-based care model treats the whole patient, focusing on patient outcomes and significantly improving how cancer care is managed.
From medical and radiation oncology, hematology, surgery, and imaging, to laboratory and pharmacy services, patients have access to important resources to enhance and facilitate their care.
Cancer biomarkers are genes and proteins on cancer cells that can be tested to learn important details about a person’s cancer. Biomarker testing helps oncologists connect patients to innovations in cancer treatment, increasing the ability of physicians to use targeted therapies and improving healthcare efficiency.
Biomarkers will increasingly be used to determine a person’s risk of future cancer development, find cancer at earlier stages, determine treatment effectiveness, and detect cancer recurrences.
Through research and clinical trials, cancer care is changing for the better. It’s becoming less about the type of cancer and more about creating treatment plans unique to each patient’s specific tumor. For more information, visit TexasOncology.com.
Great strides in cancer treatment are providing more options and improving longevity and quality of life for patients.
This article originally appeared in AARP The Magazine.
